M. H. Abdel-rahman, High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.24, issue.2, pp.288-95, 2006.

J. C. Adams, Cell-matrix contact structures, Cellular and Molecular Life Sciences, vol.58, issue.3, pp.371-392, 2001.

J. H. Ahn, Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors, 2006.

A. Q. Al-aidaroos and Q. Zeng, PRL-3 phosphatase and cancer metastasis, Journal of Cellular Biochemistry, vol.111, issue.5, pp.1087-1098, 2010.

A. Y. Alexandrova, Comparative dynamics of retrograde actin flow and focal adhesions: formation of nascent adhesions triggers transition from fast to slow flow, PloS one, vol.3, issue.9, p.3234, 2008.

C. All-ericsson, Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target, Investigative ophthalmology & visual science, vol.43, issue.1, pp.1-8, 2002.

A. Alonso, Protein Tyrosine Phosphatases in the Human Genome, Cell, vol.117, issue.6, pp.699-711, 2004.

A. Amaro, The biology of uveal melanoma, Cancer and Metastasis Reviews, 2017.

N. Amirouchene-angelozzi, The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma, Oncotarget, vol.7, issue.17, pp.23633-23646, 2016.

D. A. Andres, cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein, Cell, vol.73, issue.6, pp.1091-1100, 1993.

N. J. Anthis, ? Integrin Tyrosine Phosphorylation Is a Conserved Mechanism for Regulating Talin-induced Integrin Activation, Journal of Biological Chemistry, vol.284, issue.52, pp.36700-36710, 2009.

N. Ardjomand, Lymph node metastases arising from uveal melanoma, Wien Klin Wochenschr, vol.117, pp.433-468, 2005.

N. Babchia, The PI3K/Akt and mTOR/P70S6K Signaling Pathways in Human Uveal Melanoma Cells: Interaction with B-Raf/ERK, Investigative Opthalmology & Visual Science, vol.51, issue.1, p.421, 2010.

J. K. Baker, Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression, Melanoma research, vol.11, issue.3, pp.265-73, 2001.

C. Ballestrem, Marching at the front and dragging behind: differential alphaVbeta3-integrin turnover regulates focal adhesion behavior, The Journal of cell biology, vol.155, issue.7, pp.1319-1351, 2001.

A. Bardelli, PRL-3 expression in metastatic cancers, Clinical cancer research : an official journal of the American Association for Cancer Research, vol.9, issue.15, pp.5607-5622, 2003.

R. L. Barnhill, M. Ye, A. Batistella, and M. Stern, The biological and prognostic significance of angiotropism in uveal melanoma, Laboratory Investigation, 2017.

R. L. Barnhill, M. Ye, A. Batistella, and M. Stern, The biological and prognostic significance of angiotropism in uveal melanoma, pp.746-759, 2016.

S. H. Barsky, Loss of basement membrane components by invasive tumors but not by their benign counterparts. Laboratory investigation; a journal of technical methods and pathology, vol.49, pp.140-147, 1983.

S. Basak, The Metastasis-Associated Gene Prl-3 Is a p53 Target Involved in Cell-Cycle Regulation, Molecular Cell, vol.30, issue.3, pp.303-314, 2008.

M. D. Bass, p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4, The Journal of cell biology, vol.181, issue.6, pp.1013-1039, 2008.

J. L. Battiste, The eIF1A solution structure reveals a large RNA-binding surface important for scanning function, Molecular cell, vol.5, issue.1, pp.109-128, 2000.

A. Béliveau, Expression of integrin ?5?1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma, Investigative Ophthalmology and Visual Science, vol.41, issue.8, pp.2363-2372, 2000.

A. Béliveau, Tumorigenicity of the Mixed Spindle-Epithelioid SP6.5 and Epithelioid TP17 Uveal Melanoma Cell Lines Is Differentially Related to a5b1 Integrin Expression, 2001.

N. Benjamin-a-krantz, K. M. Dave, B. P. Komatsubara, and R. D. Carvajal, Uveal melanoma: epidemiology, etiology, and treatment of primary disease. clinical ophtalmology, 11, pp.279-289, 2017.

P. J. Ten-berge, Integrin expression in uveal melanoma differs from cutaneous melanoma, Investigative Ophthalmology and Visual Science, vol.34, issue.13, pp.3635-3640, 1993.

M. Bérubé, Role of the Extracellular Matrix Proteins in the Resistance of SP6.5 Uveal Melanoma Cells toward Cisplatin, International journal of oncology, vol.26, issue.2, pp.405-418, 2005.

D. C. Bessette, D. Qiu, and C. J. Pallen, PRL PTPs: mediators and markers of cancer progression, Cancer and Metastasis Reviews, vol.27, issue.2, pp.231-252, 2008.

D. C. Bessette, P. C. Wong, and C. J. Pallen, PRL-3: a metastasis-associated phosphatase in search of a function, Cells, tissues, organs, vol.185, issue.1-3, pp.232-238, 2007.

K. Bledzka, Tyrosine Phosphorylation of Integrin 3 Regulates Kindlin-2 Binding and Integrin Activation, Journal of Biological Chemistry, vol.285, issue.40, pp.30370-30374, 2010.

R. E. Boissy and T. J. Hornyak, Extracutaneous Melanocytes, The Pigmentary System: Physiology and Pathophysiology: Second Edition, pp.91-107, 2007.

T. Bosch, . Van-den-;-van-den, and T. Bosch, Genetics of uveal melanoma and cutaneous melanoma: Two of a kind?, Dermatology Research and Practice, issue.1, p.2010, 2010.

H. Boukerche, mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src, Proceedings of the National Academy of Sciences of the United States of America, vol.105, pp.15914-15923, 2008.

D. Bouvard, Integrin inactivators: balancing cellular functions in vitro and in vivo, Nature reviews. Molecular cell biology, vol.14, issue.7, pp.430-472, 2013.

P. C. Brooks, Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity, Cell, vol.92, issue.3, pp.391-400, 1998.

P. C. Brooks, Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin ??v??3, Cell, vol.85, issue.5, pp.683-693, 1996.

A. Broyl, Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients, Blood, vol.116, issue.14, pp.2543-53, 2010.

T. R. Burke and Z. Zhang, Protein-tyrosine phosphatases: Structure, mechanism, and inhibitor discovery, Biopolymers, vol.47, issue.3, pp.225-241, 1998.

K. Burridge and C. Guilluy, Focal adhesions , stress fi bers and mechanical tension, Experimental Cell Research, vol.343, issue.1, pp.14-20, 2015.

G. S. Butler, The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study, The Journal of biological chemistry, vol.273, issue.2, pp.871-80, 1998.

A. Calipel, Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells, The Journal of biological chemistry, vol.281, issue.14, pp.9238-50, 2006.

I. D. Campbell and M. J. Humphries, Integrin structure, activation, and interactions. Cold Spring Harbor perspectives in biology, vol.3, p.4994, 2011.

E. Capoccia, S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells, Oncology Letters, vol.9, issue.6, pp.2864-70, 2015.

G. Carita, Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma, Oncotarget, vol.7, issue.23, pp.33542-56, 2016.

D. A. Carter, Expression of a novel rat protein tyrosine phosphatase gene, Biochimica et biophysica acta, vol.1442, issue.2-3, pp.405-413, 1998.

R. D. Carvajal, Metastatic disease from uveal melanoma: treatment options and future prospects. The British journal of ophthalmology, pp.2016-309034, 2016.

L. A. Cary, J. F. Chang, and J. L. Guan, Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn, Journal of cell science, vol.109, pp.1787-94, 1996.

L. B. Case and C. M. Waterman, Integration of actin dynamics and cell adhesion by a threedimensional, mechanosensitive molecular clutch, Nature cell biology, vol.17, issue.8, pp.955-963, 2015.

N. Cassoux, Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma, The British journal of ophthalmology, vol.98, issue.6, pp.769-74, 2014.

C. A. Cates, Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases, Cancer letters, vol.110, issue.1-2, pp.49-55, 1996.

S. Di-cesare, Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF, Journal of carcinogenesis, vol.6, issue.1, p.2, 2007.

K. T. Chan, D. A. Bennin, and A. Huttenlocher, Regulation of Adhesion Dynamics by Calpainmediated Proteolysis of Focal Adhesion Kinase (FAK), Journal of Biological Chemistry, vol.285, issue.15, pp.11418-11426, 2010.

J. S. Chana, c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma, The British journal of ophthalmology, vol.83, issue.1, pp.110-114, 1999.

D. D. Chang, ICAP-1, a novel ?1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of ?1 integrin, Journal of Cell Biology, vol.138, issue.5, pp.1149-1157, 1997.

W. Chao and J. Kunz, Focal adhesion disassembly requires clathrin-dependent endocytosis of integrins, FEBS Letters, vol.583, issue.8, pp.1337-1343, 2009.

W. Chen, Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective, Journal of Immunology Research, pp.1-10, 2017.

W. T. Chen and J. Y. Wang, Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization, Annals of the New York Academy of Sciences, vol.878, pp.361-71, 1999.

X. Chen, Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations, Oncogene, vol.33, pp.4724-4734, 2013.

X. Chen, RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma, Cancer Cell, issue.5, pp.685-696, 2017.

M. Cheung, Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma, Cancer Genetics, vol.206, issue.5, pp.206-210, 2013.

C. K. Choi, Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner, Nature cell biology, vol.10, issue.9, pp.1039-50, 2008.

H. S. Choi, Poly(C)-binding proteins as transcriptional regulators of gene expression, Biochemical and biophysical research communications, vol.380, issue.3, pp.431-437, 2009.

M. S. Choi, The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability, Biochemical and Biophysical Research Communications, vol.406, issue.2, pp.305-309, 2011.

S. Choi, Biflavonoids inhibited phosphatase of regenerating liver-3 (PRL-3), Natural Product Research, vol.20, issue.4, pp.341-346, 2006.

C. Cirillo, S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease, BioMed research international, p.508342, 2015.

C. Le-clainche and M. Carlier, Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell Migration, Physiological Reviews, vol.88, issue.2, pp.489-513, 2008.

R. J. Colello and G. Jeffery, Evaluation of the influence of optic stalk melanin on the chiasmatic pathways in the developing rodent visual system, The Journal of comparative neurology, vol.305, issue.2, pp.304-316, 1991.

S. E. Coupland, Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma, The British journal of ophthalmology, vol.82, issue.8, pp.961-70, 1998.

S. E. Coupland, The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma, The Journal of pathology, vol.191, issue.2, pp.120-126, 2000.

S. E. Coupland, I. Campbell, and B. Damato, Routes of Extraocular Extension of Uveal Melanoma, Ophthalmology, vol.115, issue.10, pp.1778-1785, 2008.

L. P. Cramer, Molecular mechanism of actin-dependent retrograde flow in lamellipodia of motile cells, Frontiers in bioscience : a journal and virtual library, vol.2, pp.260-70, 1997.

D. J. Creel, C. G. Summers, and R. A. King, Visual anomalies associated with albinism, Ophthalmic Paediatrics and Genetics, vol.11, issue.3, pp.193-200, 1990.

B. Damato, Cytogenetics of uveal melanoma: a 7-year clinical experience, Ophthalmology, vol.114, issue.10, pp.1925-1956, 2007.

B. Damato, Treatment of primary intraocular melanoma, Expert review of anticancer therapy, vol.6, issue.4, pp.493-506, 2006.

B. Damato, J. A. Dopierala, and S. E. Coupland, Genotypic Profiling of 452 Choroidal Melanomas with Multiplex Ligation-Dependent Probe Amplification, Clinical Cancer Research, issue.24, p.16, 2010.

E. M. Damato and B. E. Damato, Detection and Time to Treatment of Uveal Melanoma in the United Kingdom: An Evaluation of 2384 Patients, Ophthalmology, vol.119, issue.8, pp.1582-1589, 2012.

S. Daouti, A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage, Cancer research, vol.68, issue.4, pp.1162-1171, 2008.

S. Das, Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium, Life Sciences, vol.82, issue.9, pp.467-476, 2008.

D. L. Nickla and J. Wallman, The multifunctional choroid, Prog Retin Eye Res, vol.29, issue.2, pp.144-168, 2010.

C. L. Decatur, Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes, JAMA Ophthalmology, vol.134, issue.7, pp.728-733, 2016.

S. P. Delaney, L. M. Julian, and W. L. Stanford, The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis, Frontiers in Cell and Developmental Biology, vol.2, p.69, 2014.

J. S. Desgrosellier and D. Cheresh, Integrins in cancer: biological implications and therapeutic opportunities, Nature reviews. Cancer, vol.10, issue.1, pp.9-22, 2010.

R. H. Diamond, Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine, The American journal of physiology, vol.271, issue.1, pp.121-130, 1996.

R. H. Diamond, PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth, Molecular and cellular biology, vol.14, issue.6, pp.3752-62, 1994.

S. Dithmar, C. E. Diaz, and H. E. Grossniklaus, Intraocular melanoma spread to regional lymph nodes: report of two cases, Retina, vol.20, issue.1, pp.76-85, 2000.

Y. Dong, Phosphatase of Regenerating Liver 2 (PRL2) Deficiency Impairs Kit Signaling and Spermatogenesis, Journal of Biological Chemistry, vol.289, issue.6, pp.3799-3810, 2014.

Y. Dong, Phosphatase of regenerating liver 2 (PRL2) is essential for placental development by down-regulating PTEN (phosphatase and tensin homologue deleted on chromosome 10) and activating Akt protein, Journal of Biological Chemistry, vol.287, issue.38, pp.32172-32179, 2012.

N. Le-douarin and C. Kalcheim, The neural crest, 1999.
URL : https://hal.archives-ouvertes.fr/hal-02188723

J. Duband, Diversity in the molecular and cellular strategies of epithelium-to-mesenchyme transitions: Insights from the neural crest, Cell adhesion & migration, vol.4, issue.3, pp.458-82, 2010.

J. Duband, Neural Crest Delamination and Migration, Neural Crest Induction and Differentiation, pp.45-77, 2006.

A. D. Dubash, A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA activity downstream of adhesion to fibronectin, Journal of Cell Science, vol.120, issue.22, pp.3989-3998, 2007.

. Dulbecco, Encyclopedia of Human Biology: Si-Z -Page 597, p.812, 1997.

M. A. Economou, Receptors for the Liver Synthesized Growth Factors IGF-1 and HGF/SF in Uveal Melanoma: Intercorrelation and Prognostic Implications, Investigative Opthalmology & Visual Science, vol.46, issue.12, p.4372, 2005.

J. P. Ehlers, DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma, Clinical Cancer Research, vol.11, issue.10, pp.3609-3613, 2005.

J. P. Ehlers, Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma, vol.14, pp.115-123, 2008.

J. P. Ehlers and J. W. Harbour, NBS1 Expression as a Prognostic Marker in Uveal Melanoma, Clin. Cancer Res, vol.11, issue.5, pp.1849-1853, 2005.

M. Eldh, MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma, BMC Cancer, vol.14, issue.1, p.962, 2014.

Z. M. Eletr and K. D. Wilkinson, An emerging model for BAP1's role in regulating cell cycle progression, Cell biochemistry and biophysics, vol.60, pp.3-11, 2011.

S. G. Elner and V. M. Elner, The integrin superfamily and the eye, Investigative ophthalmology & visual science, vol.37, issue.5, pp.696-701, 1996.

S. R. Elshaw, A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins, The British journal of ophthalmology, vol.85, issue.6, pp.732-740, 2001.

E. Von-euw, Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines, Molecular Cancer, vol.11, issue.1, p.22, 2012.

E. J. Ezratty, Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells, The Journal of cell biology, vol.187, issue.5, pp.733-780, 2009.

U. Fagerli, Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells, Blood, vol.111, issue.2, pp.806-821, 2008.

P. Fagone, Identification of novel chemotherapeutic strategies for metastatic uveal melanoma, Scientific Reports, vol.7, p.44564, 2017.

X. Fang, PRL-3 Promotes the Malignant Progression of Melanoma via Triggering Dephosphorylation and Cytoplasmic Localization of NHERF1, Journal of Investigative Dermatology, vol.135, issue.9, pp.2273-2282, 2015.

X. Feng, Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a Trio-regulated Rho GTPase Signaling Circuitry, Cancer Cell, issue.6, p.25, 2014.

M. G. Field, Biology of Human Tumors PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma, Clin Cancer Res, vol.22, issue.5, pp.1234-1276, 2016.

J. J. Fiordalisi, Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion, PLoS ONE, vol.8, issue.5, p.64309, 2013.

J. J. Fiordalisi, P. J. Keller, and A. D. Cox, PRL tyrosine phosphatases regulate Rho family GTPases to promote invasion and motility, Cancer Research, vol.66, issue.6, pp.3153-3161, 2006.

T. L. Flanigan, The effects of increased extracellular deformation, pressure, and integrin phosphorylation on fibroblast migration, The Journal of surgical research, vol.156, issue.1, pp.103-112, 2009.

E. Forte, Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3, Biochimica et biophysica acta, vol.1783, issue.2, pp.334-378, 2008.

S. J. Franco, Calpain-mediated proteolysis of talin regulates adhesion dynamics, Nature Cell Biology, vol.6, issue.10, pp.977-983, 2004.

P. Friedl and E. B. Bröcker, The biology of cell locomotion within three-dimensional extracellular matrix, Cellular and Molecular Life Sciences, vol.57, issue.1, pp.41-64, 2000.

P. Friedl and K. Wolf, Plasticity of cell migration: A multiscale tuning model, Journal of Cell Biology, vol.188, issue.1, pp.11-19, 2010.

P. Friedl and K. Wolf, Tumour-cell invasion and migration: diversity and escape mechanisms, Nature reviews. Cancer, vol.3, issue.5, pp.362-74, 2003.

K. A. Furge, Y. Zhang, and G. F. Vande-woude, Met receptor tyrosine kinase: enhanced signaling through adapter proteins, Oncogene, vol.19, issue.49, pp.5582-5589, 2000.

T. F. Gajewski, Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104), Journal of translational medicine, vol.10, issue.1, p.246, 2012.

C. G. Galbraith, K. M. Yamada, and M. P. Sheetz, The relationship between force and focal complex development, The Journal of cell biology, vol.159, issue.4, pp.695-705, 2002.

B. G. Gálvez, ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells, The Journal of cell biology, vol.159, issue.3, pp.509-530, 2002.

L. S. Gammill and M. Bronner-fraser, Neural crest specification: migrating into genomics, Nature reviews. Neuroscience, vol.4, issue.10, pp.795-805, 2003.

R. Gangemi, Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression, PLoS ONE, vol.7, issue.1, 2012.

B. Geiger, J. P. Spatz, and A. D. Bershadsky, Environmental sensing through focal adhesions, Nature Reviews Molecular Cell Biology, vol.10, issue.1, pp.21-33, 2009.

B. Geiger and K. M. Yamada, Molecular Architecture and Function of Matrix Adhesions, Cold Spring Harbor Perspectives in Biology, vol.3, issue.5, pp.5033-005033, 2011.

F. G. Giancotti and G. Tarone, Positional control of cell fate through joint integrin/receptor protein kinase signaling, Annual review of cell and developmental biology, vol.19, issue.1, pp.173-206, 2003.

A. Girnita, Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth, Cancer Research, vol.64, issue.1, pp.236-242, 2004.

A. Girnita, The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells, Acta Ophthalmologica, vol.86, pp.26-34, 2008.

K. Guo, Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels, Cancer biology & therapy, vol.3, issue.10, pp.945-51, 2004.

K. Guo, PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo, Cancer Research, 2006.

W. Guo and F. G. Giancotti, Integrin signalling during tumour progression, Nature reviews. Molecular cell biology, vol.5, issue.10, pp.816-826, 2004.

Y. Han, Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity, Bioorganic & medicinal chemistry letters, vol.22, issue.1, pp.323-329, 2012.

D. Hanahan and R. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, issue.5, pp.646-74, 2011.

J. W. Harbour, Frequent mutation of BAP1 in metastasizing uveal melanomas, Science, issue.6009, pp.1410-1413, 2010.

J. W. Harbour, Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma, Nature genetics, vol.45, issue.2, pp.133-138, 2013.

J. W. Harbour, The genetics of uveal melanoma: an emerging framework for targeted therapy, Pigment cell & melanoma research, vol.25, issue.2, pp.171-81, 2012.

S. Hardy, Overexpression of the Protein Tyrosine Phosphatase PRL-2 Correlates with Breast Tumor Formation and Progression, Cancer Research, vol.70, issue.21, pp.8959-8967, 2010.

N. M. Hassan, Increased expression of the PRL-3 gene in human oral squamous cell carcinoma and dysplasia tissues, Asian Pacific journal of cancer prevention : APJCP, vol.12, issue.4, pp.947-51, 2011.

E. L. Hastie and D. R. Sherwood, A new front in cell invasion: The invadopodial membrane, European Journal of Cell Biology, vol.95, issue.11, pp.441-448, 2016.

H. Helgadottir and V. H??iom, The genetics of uveal melanoma: Current insights, Application of Clinical Genetics, vol.9, pp.147-155, 2016.

B. M. Helmke, Melanoma metastasis is associated with enhanced expression of the syntenin gene, Oncology reports, vol.12, issue.2, pp.221-229, 2004.

F. Henriquez, The T1799A BRAF mutation is present in iris melanoma, Investigative Ophthalmology and Visual Science, vol.48, issue.11, pp.4897-4900, 2007.

J. D. Hildebrand, J. M. Taylor, and J. T. Parsons, An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase, Molecular and cellular biology, vol.16, issue.6, pp.3169-78, 1996.

P. Hollander, Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival, Cancer Research, issue.7, p.76, 2016.

M. Hollstein, p53 mutations in human cancers, Science, issue.5015, pp.49-53, 1991.

A. Hoshino, Tumour exosome integrins determine organotropic metastasis, 2015.

D. Hoshino, K. M. Branch, and A. M. Weaver, Signaling inputs to invadopodia and podosomes, Journal of Cell Science, vol.126, issue.14, pp.2979-2989, 2013.

M. Y. Hsu, Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. The American journal of pathology, vol.153, pp.1435-1477, 1998.

Y. Huang, A role of autophagy in PTP4A3-driven cancer progression, Autophagy, vol.10, issue.10, pp.1787-800, 2014.

S. Hughes, Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3, British Journal of Cancer, vol.93, issue.10, pp.1191-1196, 2005.

J. D. Humphries, Vinculin controls focal adhesion formation by direct interactions with talin and actin, The Journal of Cell Biology, vol.179, issue.5, pp.1043-1057, 2007.

R. O. Hynes, Integrins: A family of cell surface receptors, Cell, vol.48, issue.4, pp.549-554, 1987.

R. O. Hynes, Integrins: Bidirectional, allosteric signaling machines, Cell, vol.110, issue.6, pp.673-687, 2002.

N. Ibrahim and F. G. Haluska, Molecular Pathogenesis of Cutaneous Melanocytic Neoplasms, Annual Review of Pathology: Mechanisms of Disease, vol.4, issue.1, pp.551-579, 2009.

D. Ili?, Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice, Nature, vol.377, issue.6549, pp.539-583, 1995.

N. Inagaki and H. Katsuno, Actin Waves: Origin of Cell Polarization and Migration?, Trends in Cell Biology, vol.27, issue.7, pp.515-526, 2017.

T. Ishii, Y. Funato, and H. Miki, Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL), The Journal of biological chemistry, vol.288, issue.10, pp.7263-70, 2013.

V. Jay, Expression of bcl-2 in uveal malignant melanoma. Archives of pathology & laboratory medicine, vol.120, pp.497-505, 1996.

D. G. Jeong, Trimeric Structure of PRL-1 Phosphatase Reveals an Active Enzyme Conformation and Regulation Mechanisms, Journal of Molecular Biology, vol.345, issue.2, pp.401-413, 2005.

Y. Jiang, Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis, Cancer research, vol.71, issue.1, pp.234-278, 2011.

P. Johansson, Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4, Oncotarget, vol.7, issue.4, pp.4624-4655, 2016.

R. Kalluri, Basement membranes: structure, assembly and role in tumour angiogenesis, Nature reviews. Cancer, vol.3, issue.6, pp.422-455, 2003.

H. Kato, High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases, Clinical cancer research : an official journal of the American Association for Cancer Research, vol.10, issue.21, pp.7318-7346, 2004.

T. Kiema, The molecular basis of filamin binding to integrins and competition with talin, Molecular cell, vol.21, issue.3, pp.337-384, 2006.

E. Kilic, Clinical and Cytogenetic Analyses in Uveal Melanoma, Investigative Opthalmology & Visual Science, vol.47, issue.9, p.3703, 2006.

K. Kim, Structure of human PRL-3 , the phosphatase associated with cancer metastasis, vol.565, pp.181-187, 2004.

J. Kobayashi, Bisbenzamidine derivative, pentamidine represses DNA damage response through inhibition of histone H2A acetylation, Molecular cancer, vol.9, p.34, 2010.

M. Kobayashi, PRL2/PTP4A2 Phosphatase Is Important for Hematopoietic Stem Cell Self-Renewal, STEM CELLS, vol.32, issue.7, pp.1956-1967, 2014.

L. Kong, The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas, Neuropathology, vol.27, issue.6, pp.516-521, 2007.

W. Kong, PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues, American journal of physiology. Gastrointestinal and liver physiology, vol.279, issue.3, pp.613-634, 2000.

P. A. Konstantinopoulos, M. V. Karamouzis, and A. G. Papavassiliou, Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets, Nature Reviews Drug Discovery, vol.6, issue.7, pp.541-555, 2007.

G. Kozlov, Structural Insights into Molecular Function of the Metastasis-associated Phosphatase PRL-3, Journal of Biological Chemistry, vol.279, issue.12, pp.11882-11889, 2004.

D. Krndija, The phosphatase of regenerating liver 3 (PRL-3) promotes cell migration through Arf-activity-dependent stimulation of integrin ?5 recycling, Journal of cell science, vol.125, pp.3883-92, 2012.

J. Kuo, Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for ?-Pix in negative regulation of focal adhesion maturation, Nature Cell Biology, vol.13, issue.4, pp.383-393, 2011.

J. Kuo, Mechanotransduction at focal adhesions: integrating cytoskeletal mechanics in migrating cells, Journal of cellular and molecular medicine, pp.1-9, 2013.

B. Ladoux, R. M. Mège, and X. Trepat, Front-Rear Polarization by Mechanical Cues: From Single Cells to Tissues, Trends in Cell Biology, vol.26, issue.6, pp.420-433, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01307708

S. Landreville, Suppression of ?5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines, Pigment cell & melanoma research, vol.24, issue.4, pp.643-55, 2011.

J. S. Laurence, K. Hallenga, and C. V. Stauffacher, 1H, 15N, 13C resonance assignments of the human protein tyrosine phosphatase PRL-1, Journal of biomolecular NMR, vol.29, issue.3, pp.417-425, 2004.

C. Laurent, High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients, Cancer research, vol.71, issue.3, pp.666-74, 2011.

C. Laurent, Patient-derived xenografts recapitulate molecular features of human uveal melanomas, Molecular Oncology, vol.7, issue.3, pp.625-636, 2013.

D. A. Law, Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function, Nature, vol.401, issue.6755, pp.808-819, 1999.

S. K. Lee, Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells, International Journal of Cancer, vol.131, issue.3, pp.190-203, 2012.

K. R. Legate and R. Fässler, Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails, Journal of cell science, vol.122, pp.187-98, 2009.

E. C. Lerner, Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes, Journal of Biological Chemistry, vol.270, issue.45, pp.26802-26806, 1995.

H. Li, Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases, Investigative ophthalmology & visual science, vol.50, issue.12, pp.5522-5530, 2009.

Z. Li, MiR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3, Cancer Letters, vol.323, issue.1, pp.41-47, 2012.

S. Lian, PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer, Oncology letters, vol.12, issue.3, pp.1661-1666, 2016.

S. Lian, PRL-3 promotes telomere deprotection and chromosomal instability, Nucleic Acids Research, vol.45, issue.11, pp.6546-6571, 2017.

F. Liang and J. Liang, PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation, The Journal of biological chemistry, vol.282, issue.8, pp.5413-5422, 2007.

F. Liang, Y. Luo, Y. Dong, and C. D. Walls, Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase, Journal of Biological Chemistry, vol.283, issue.16, pp.10339-10346, 2008.

F. Liang, Y. Luo, Y. Dong, and C. D. Walls, Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase, The Journal of biological chemistry, vol.283, issue.16, pp.10339-10385, 2008.

F. Liang, S. Kumar, and Z. Zhang, Proteomic approaches to studying protein tyrosine phosphatases, Molecular bioSystems, vol.3, issue.5, pp.308-324, 2007.

Y. Lim, PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility, The Journal of Cell Biology, vol.180, issue.1, pp.187-203, 2008.

M. Lin, Expression of phosphatase of regenerating liver family genes during embryogenesis: an evolutionary developmental analysis among Drosophila, amphioxus, and zebrafish, BMC developmental biology, vol.13, issue.1, p.18, 2013.

S. Lin, Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in nonsmall cell lung cancer by regulating the epithelial-mesenchymal transition, Oncotarget, vol.7, issue.16, pp.21799-21811, 2016.

L. A. Liotta and E. C. Kohn, The microenvironment of the tumour-host interface, Nature, issue.6835, pp.375-384, 2001.

Y. Liu, PRL-3 promotes epithelial mesenchymal transition by regulating cadherin directly, Cancer Biology and Therapy, vol.8, issue.14, pp.1352-1359, 2009.

Y. Liu, Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma. Archives of pathology & laboratory medicine, vol.132, pp.1307-1319, 2008.

J. J. Luke, Biology of advanced uveal melanoma and next steps for clinical therapeutics, Pigment Cell and Melanoma Research, vol.28, issue.2, pp.135-147, 2014.

Y. Luo, F. Liang, and Z. Zhang, PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways, Biochemistry, vol.48, issue.8, pp.1838-1884, 2009.

Y. Ma and B. Li, Expression of phosphatase of regenerating liver-3 in squamous cell carcinoma of the cervix, Medical oncology, vol.28, issue.3, pp.775-80, 2011.

S. Maacha, Protein tyrosine phosphatase 4A3 (PTP4A3) is required for Xenopus laevis cranial neural crest migration in vivo, PloS one, vol.8, issue.12, p.84717, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01183649

Y. J. Machida, The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1, Journal of Biological Chemistry, vol.284, issue.49, pp.34179-34188, 2009.

A. Mahipal, A pilot study of sunitinib malate in patients with metastatic uveal melanoma, Melanoma Research, vol.22, issue.6, pp.440-446, 2012.

G. Maity, Fibronectin?integrin mediated signaling in human cervical cancer cells (SiHa), Molecular and Cellular Biochemistry, vol.336, issue.1-2, pp.65-74, 2010.

G. Maity, T. Sen, and A. Chatterjee, Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa), Journal of Cancer Research and Clinical Oncology, vol.137, issue.2, pp.347-357, 2011.

T. Mäkitie, Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma, Investigative Ophthalmology and Visual Science, vol.42, issue.11, pp.2442-2449, 2001.

K. Mallikarjuna, Expression of Epidermal Growth Factor Receptor: Risk Factor in Uveal Melanoma, Current eye research, vol.32, issue.3, pp.1-5, 2013.

C. Margadant, Mechanisms of integrin activation and trafficking. Current opinion in cell biology, vol.23, pp.607-621, 2011.

J. Marshall, Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas, British Joumal of Cancer, vol.77, issue.4, pp.522-529, 1998.

M. Martin, Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3, Nature genetics, vol.45, issue.8, pp.933-939, 2013.

W. F. Matter, Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling, Biochemical and biophysical research communications, vol.283, issue.5, pp.1061-1069, 2001.

V. Mcparland, The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides, Biochemistry, vol.50, issue.35, pp.7579-7590, 2011.

D. Michaelson, Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding, The Journal of cell biology, vol.152, issue.1, pp.111-137, 2001.

G. Min, Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells, Bioorganic & medicinal chemistry letters, vol.23, issue.13, pp.3769-74, 2013.

S. Min, Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2, Life Sciences, vol.86, issue.1, pp.66-72, 2010.

J. Ming, PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer, Pathology, vol.41, issue.2, pp.118-144, 2009.

S. Misaghi, Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1, Molecular and cellular biology, vol.29, issue.8, pp.2181-92, 2009.

U. A. Miskad, Expression of PRL-3 Phosphatase in Human Gastric Carcinomas: Close Correlation with Invasion and Metastasis, Pathobiology, vol.71, issue.4, pp.176-184, 2004.

U. A. Miskad, High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: An in situ hybridization study, Virchows Archiv, vol.450, issue.3, pp.303-310, 2007.

S. K. Mitra and D. D. Schlaepfer, Integrin-regulated FAK-Src signaling in normal and cancer cells. Current opinion in cell biology, vol.18, pp.516-539, 2006.

E. Mizuuchi, Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression, International Journal of Cancer, vol.124, issue.8, pp.1802-1810, 2009.

K. L. Mohn, The gene encoding rat insulinlike growth factor-binding protein 1 is rapidly and highly induced in regenerating liver, Molecular and cellular biology, vol.11, issue.3, pp.1393-1401, 1991.

M. Montagna, Localization of the human phosphotyrosine phosphatase-related genes (h-PRL-1) to chromosome bands 1p35-p34, 17q12-q21, 11q24-q25 and 12q24, Human genetics, vol.98, issue.6, pp.738-778, 1996.

A. R. Moore, Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma, Nature genetics, advance on, issue.6, pp.675-680, 2016.

H. Mori, Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin ?1, Development, vol.140, issue.2, pp.343-52, 2013.

M. Moser, Kindlin-3 is essential for integrin activation and platelet aggregation, Nature medicine, vol.14, issue.3, pp.325-355, 2008.

F. Mouriaux, Journal francais d'ophtalmologie, vol.22, issue.7, pp.799-809, 1999.

F. Mouriaux, Les mélanocytes choroïdiens normaux et malins : de la cellule à la clinique, 2005.

F. Mouriaux, Sorafenib in metastatic uveal melanoma : efficacy , toxicity and health-related quality of life in a multicentre phase II study, British Journal of Cancer, vol.115, issue.1, pp.20-24, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02358580

H. Nagase, R. Visse, and G. Murphy, Structure and function of matrix metalloproteinases and TIMPs, Cardiovascular Research, vol.69, issue.3, pp.562-573, 2006.

T. Nayman, Uveal Melanoma Risk Factors: A Systematic Review of Meta-Analyses, pp.1-9, 2017.

J. Nevo, Mammary-derived growth inhibitor (MDGI) interacts with integrin ?-subunits and suppresses integrin activity and invasion, Oncogene, vol.29, issue.49, pp.6452-63, 2010.

B. Nieswandt, Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo, The Journal of experimental medicine, vol.204, issue.13, pp.3113-3121, 2007.

B. Nieves, The NPIY motif in the integrin beta1 tail dictates the requirement for talin-1 in outside-in signaling, Journal of cell science, vol.123, pp.1216-1242, 2010.

S. Nilsson, Threonine 788 in integrin subunit beta1 regulates integrin activation, Experimental cell research, issue.6, pp.844-53, 2006.

T. Nishimura and K. Kaibuchi, Numb Controls Integrin Endocytosis for Directional Cell Migration with aPKC and PAR-3, Developmental Cell, vol.13, issue.1, pp.15-28, 2007.

D. M. Noden, R. E. Poelmann, and A. C. Gittenberger-de-groot, Cell origins and tissue boundaries during outflow tract development, Trends in cardiovascular medicine, vol.5, issue.2, pp.69-75, 1995.

M. D. Onken, An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal Melanoma, The Journal of Molecular Diagnostics, vol.12, issue.4, pp.461-468, 2010.

M. D. Onken, Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death, CANCER RESEARCH, vol.64, pp.7205-7209, 2004.

M. D. Onken, Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma, Clinical Cancer Research, vol.13, issue.10, pp.2923-2927, 2007.

M. D. Onken, Oncogenic mutations in GNAQ occur early in uveal melanoma, Investigative ophthalmology & visual science, vol.49, issue.12, pp.5230-5234, 2008.

A. Ooki, Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma, International journal of cancer, vol.127, issue.3, pp.543-54, 2010.

A. Ooki, Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer, BMC cancer, vol.11, issue.1, p.122, 2011.

L. Orsatti, 2-D difference in gel electrophoresis combined with Pro-Q Diamond staining: A successful approach for the identification of kinase/phosphatase targets, Electrophoresis, vol.30, issue.14, pp.2469-2476, 2009.

A. Östman, C. Hellberg, and F. D. Böhmer, Protein-tyrosine phosphatases and cancer, Nature Reviews Cancer, vol.6, issue.4, pp.307-320, 2006.

J. D. Owen, Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto-and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2, Molecular and cellular biology, vol.19, issue.7, pp.4806-4824, 1999.

C. L. Oxley, An integrin phosphorylation switch: The effect of ??3 integrin tail phosphorylation on Dok1 and talin binding, Journal of Biological Chemistry, vol.283, issue.9, pp.5420-5426, 2008.

H. Park, Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening, Bioorganic & Medicinal Chemistry Letters, vol.18, issue.7, pp.2250-2255, 2008.

M. Pascaru, Analysis of molecular determinants of PRL-3, Journal of Cellular and Molecular Medicine, vol.13, issue.9, pp.3141-3150, 2009.

M. K. Pathak, Pentamidine is an inhibitor of PRL phosphatases with anticancer activity, Molecular cancer therapeutics, vol.1, issue.14, pp.1255-64, 2002.

J. M. Paul and . Berge, Integrin Expression in Uveal Melanoma Differs From Cutaneous Melanoma, Investigative Ophthalmology and Visual Science, vol.34, issue.13, pp.3635-3640, 1993.

K. Pekka and H. Jyrki, Integrins in Cancer Cell Invasion, pp.1-23, 2013.

L. Peng, Identification of integrin ??1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochemical and Biophysical Research Communications, vol.342, pp.179-183, 2006.

L. Peng, PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling, Molecular cancer, vol.8, p.110, 2009.

L. Peng, The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer, Journal of Cancer Research and Clinical Oncology, vol.130, issue.9, pp.521-527, 2004.

B. Peruzzi and D. P. Bottaro, Targeting the c-Met signaling pathway in cancer, Clinical cancer research : an official journal of the American Association for Cancer Research, vol.12, issue.12, pp.3657-60, 2006.

B. G. Petrich, Talin is required for integrin-mediated platelet function in hemostasis and thrombosis, The Journal of Experimental Medicine, vol.204, issue.13, pp.3103-3111, 2007.

A. Pfeifer, Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2, Proceedings of the National Academy of Sciences of the United States of America, vol.97, pp.12227-12259, 2000.

P. M. Plonka, What are melanocytes really doing all day long, Experimental dermatology, vol.18, issue.9, pp.799-819, 2009.

R. Poincloux, F. Lizarraga, and P. Chavrier, Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia, Journal of Cell Science, vol.122, issue.17, pp.3015-3024, 2009.

F. Polato, PRL-3 phosphatase is implicated in ovarian cancer growth, Clinical Cancer Research, vol.11, pp.6835-6839, 2005.

A. Ponti, Two distinct actin networks drive the protrusion of migrating cells, Science, issue.5691, pp.1782-1788, 2004.

S. Qu, Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia, Cancer, vol.120, issue.14, pp.2130-2141, 2014.

V. Quesada, Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia, Nature genetics, vol.44, issue.1, pp.47-52, 2011.

C. D. Van-raamsdonk, Mutations in GNA11 in uveal melanoma, The New England journal of medicine, vol.363, issue.23, pp.2191-2200, 2010.

G. Rabinowits, Exosomal microRNA: a diagnostic marker for lung cancer, Clinical lung cancer, vol.10, issue.1, pp.42-48, 2009.

I. Radke, Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer, British journal of cancer, vol.95, issue.3, pp.347-54, 2006.

K. Rai, Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases, Clinical Genetics, vol.89, issue.3, pp.285-294, 2016.

K. Rai, Germline BAP1 alterations in familial uveal melanoma, Genes Chromosomes and Cancer, vol.56, issue.2, pp.168-174, 2017.

J. K. Rantala, SHARPIN is an endogenous inhibitor of ?1-integrin activation, Nature cell biology, vol.13, issue.11, pp.1315-1339, 2011.

D. Reinhold, MDA-9/syntenin: a positive gatekeeper of melanoma metastasis, pp.2356-2363, 2008.

L. Ren and C. Khanna, Role of ezrin in osteosarcoma metastasis, Advances in Experimental Medicine and Biology, vol.804, pp.181-201, 2015.

T. Ren, Prognostic Significance of Phosphatase of Regenerating Liver-3 Expression in Ovarian Cancer, Pathology & Oncology Research, vol.15, issue.4, pp.555-560, 2009.

P. Rios, X. Li, and M. Köhn, Molecular mechanisms of the PRL phosphatases, FEBS Journal, vol.280, pp.505-524, 2012.

U. Rodeck, Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes, The Journal of investigative dermatology, vol.97, issue.1, pp.20-26, 1991.

M. Rolli, Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells, Proceedings of the National Academy of Sciences of the United States of America, vol.100, pp.9482-9489, 2003.

B. Royer-bertrand, Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing, American Journal of Human Genetics, vol.99, issue.5, pp.1190-1198, 2016.

T. Rubio and M. Köhn, Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3, Biochemical Society transactions, vol.44, issue.5, pp.1305-1312, 2016.

S. Saha, A phosphatase associated with metastasis of colorectal cancer, Science, vol.294, issue.5545, pp.1343-1349, 2001.

T. Sakai, Modulation of beta1A integrin functions by tyrosine residues in the beta1 cytoplasmic domain, The Journal of cell biology, vol.141, issue.2, pp.527-565, 1998.

K. Saladin, Anatomy & Physiology: The Unity of Form and Function, Anatomy & Physiology: The Unity of Form and Function, p.1248, 2014.

A. R. Saltiel and C. R. Kahn, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, vol.414, issue.6865, pp.799-806, 2001.

M. Sands, M. A. Kron, and R. B. Brown, Pentamidine: A Review, Clinical Infectious Diseases, vol.7, issue.5, pp.625-6344, 1985.

V. Sanz-moreno and C. J. Marshall, The plasticity of cytoskeletal dynamics underlying neoplastic cell migration, Current Opinion in Cell Biology, vol.22, issue.5, pp.690-696, 2010.

M. A. Saornil, Canadian journal of ophthalmology, Journal canadien d'ophtalmologie, vol.39, issue.4, pp.448-52, 2004.

V. S. Saraiva, Immunohistochemical expression of phospho-Akt in uveal melanoma, Melanoma research, vol.15, issue.4, pp.245-50, 2005.

S. Scala, CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type, Cancer Immunology, Immunotherapy, vol.56, issue.10, pp.1589-1595, 2007.

D. D. Schlaepfer, FAK integrates growth-factor and integrin signals to promote cell migration, Nature Cell Biology, vol.2, issue.5, pp.249-256, 2000.

M. Schober, Focal adhesion kinase modulates tension signaling to control actin and focal adhesion dynamics, The Journal of Cell Biology, vol.176, issue.5, pp.667-680, 2007.

A. G. Scholes, Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival, Investigative ophthalmology & visual science, vol.44, issue.3, pp.1008-1019, 2003.

M. A. Schwartz, Integrin signaling revisited, Trends in cell biology, vol.11, issue.12, pp.466-70, 2001.

M. C. Seabra, Rab geranylgeranyl transferase. A multisubunit enzyme that prenylates GTPbinding proteins terminating in Cys-X-Cys or Cys-Cys, The Journal of biological chemistry, vol.267, issue.20, pp.14497-503, 1992.

S. Semba, E. Mizuuchi, and H. Yokozaki, Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma, Cancer Science, 2010.

C. P. Shah, Intermittent and chronic ultraviolet light exposure and uveal melanoma: a metaanalysis, Ophthalmology, vol.112, issue.9, pp.1599-607, 2005.

S. J. Shattil, C. Kim, and M. H. Ginsberg, The final steps of integrin activation: the end game, Nature reviews. Molecular cell biology, vol.11, issue.4, pp.288-300, 2010.

D. R. Sherwood, Cell invasion through basement membranes: an anchor of understanding, Trends in cell biology, vol.16, issue.5, pp.250-256, 2006.

T. Shibue and R. A. Weinberg, Integrin ?1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs, Proceedings of the National Academy of Sciences, vol.106, issue.25, pp.10290-10295, 2009.

C. L. Shields, J. G. Kels, and J. A. Shields, Melanoma of the eye: Revealing hidden secrets, one at a time, Clinics in Dermatology, vol.33, issue.2, pp.183-196, 2015.

J. A. Shields, C. L. Shields, and J. A. Shields, Intraocular tumors : an atlas and textbook, 2008.

X. Si, Interaction of Farnesylated PRL-2, a Protein-tyrosine Phosphatase, with the -Subunit of Geranylgeranyltransferase II, Journal of Biological Chemistry, vol.276, issue.35, pp.32875-32882, 2001.

D. J. Sieg, C. R. Hauck, and D. D. Schlaepfer, Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration, Journal of Cell Science, issue.16, p.112, 1999.

S. Silletti, Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo, Proceedings of the National Academy of Sciences, vol.98, issue.1, pp.119-124, 2001.

A. Singh, Uveal Melanoma: Epidemiologic Aspects, Ophthalmology Clinics of North America, vol.18, issue.1, pp.75-84, 2005.

A. D. Singh, Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis, Ophthalmology, vol.105, issue.1, pp.195-203, 1998.

A. D. Singh, P. Kalyani, and A. Topham, Estimating the risk of malignant transformation of a choroidal nevus, Ophthalmology, vol.112, issue.10, pp.1784-1789, 2005.

A. D. Singh, M. E. Turell, and A. K. Topham, Uveal Melanoma: Trends in Incidence, Treatment, and Survival, Ophthalmology, vol.118, issue.9, pp.1881-1885, 2011.

J. Skog, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nature cell biology, vol.10, issue.12, pp.1470-1476, 2008.

J. Smith, The effect of pentamidine on melanoma. Anti-cancer drugs, vol.21, pp.181-186, 2010.

S. D. Smith, Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF, Journal of medical genetics, vol.37, issue.6, pp.446-454, 2000.

R. Song, Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo, PloS one, vol.4, issue.2, p.4450, 2009.

M. Stefanidakis and E. Koivunen, Cell-surface association between matrix metalloproteinases and integrins: Role of the complexes in leukocyte migration and cancer progression, Blood, vol.108, issue.5, pp.1441-1450, 2006.

B. Stephens, Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells, Molecular cancer therapeutics, vol.7, issue.1, pp.202-212, 2008.

B. J. Stephens, PRL phosphatases as potential molecular targets in cancer, Molecular cancer therapeutics, vol.4, issue.11, pp.1653-61, 2005.

J. Sun, Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration, The Journal of biological chemistry, vol.282, issue.39, pp.29043-51, 2007.

J. P. Sun, Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion, Biochemistry, vol.44, issue.36, pp.12009-12021, 2005.

Y. Takada, X. Ye, and S. Simon, The integrins, Genome biology, vol.8, issue.5, p.215, 2007.

S. Takano, PRL-1, a protein tyrosine phosphatase, is expressed in neurons and oligodendrocytes in the brain and induced in the cerebral cortex following transient forebrain ischemia. Brain research, Molecular brain research, vol.40, issue.1, pp.105-120, 1996.

W. Tian, Phosphatase of regenerating liver-3 directly interacts with integrin ?1 and regulates its phosphorylation at tyrosine 783, BMC biochemistry, vol.13, issue.1, p.22, 2012.

J. Trolet, Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases, Investigative ophthalmology & visual science, vol.50, issue.6, pp.2572-80, 2009.

S. Tshori, Transcription factor MITF regulates cardiac growth and hypertrophy, The Journal of clinical investigation, vol.116, issue.10, pp.2673-81, 2006.

M. Tulla, Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains, The Journal of biological chemistry, vol.276, issue.51, pp.48206-48218, 2001.

D. Valdembri and G. Serini, Regulation of adhesion site dynamics by integrin traffic. Current opinion in cell biology, vol.24, pp.582-91, 2012.

P. Vallotton, Tracking Retrograde Flow in Keratocytes: News from the Front, Molecular Biology of the Cell, vol.16, issue.3, pp.1223-1231, 2005.

E. N. Vandsemb, Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration, Journal of Translational Medicine, vol.14, issue.1, p.71, 2016.

M. Versluis, ERK activation and monosomy 3 are associated with Src expression in uveal melanoma and may serve as biomarkers for Dasatinib treatment, Acta Ophthalmologica, vol.89, issue.s248, pp.0-0, 2011.

M. Vicente-manzanares, Regulation of protrusion, adhesion dynamics, and polarity by myosins IIA and IIB in migrating cells, The Journal of Cell Biology, vol.176, issue.5, pp.573-580, 2007.

M. Vicente-manzanares, C. K. Choi, and A. R. Horwitz, Integrins in cell migration--the actin connection, Journal of Cell Science, vol.122, issue.2, pp.199-206, 2009.

J. L. Vidal, Melanoma 92". epidemiological study of uveal melanoma in France, Journal francais d'ophtalmologie, vol.18, issue.8-9, pp.520-528, 1995.

G. Virgili, Incidence of Uveal Melanoma in Europe, Ophthalmology, vol.114, issue.12, pp.2309-2315, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00492638

T. M. Walker, Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma, Archives of ophthalmology, vol.120, issue.12, pp.1719-1744, 1960.

H. Wang, PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase, Cancer cell, vol.18, issue.1, pp.52-62, 2010.

H. Wang, PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition, Cancer Research, vol.67, issue.7, pp.2922-2926, 2007.

J. Wang, C. E. Kirby, and R. Herbst, The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis, Journal of Biological Chemistry, vol.277, issue.48, pp.46659-46668, 2002.

L. Wang, An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells, Molecular Pharmacology, vol.76, issue.6, pp.1238-1245, 2009.

L. Wang, Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome, Annals of Oncology, vol.17, issue.10, pp.1517-1522, 2006.

M. Wang and P. J. Casey, Protein prenylation: unique fats make their mark on biology, Nature Reviews Molecular Cell Biology, vol.17, issue.2, pp.110-122, 2016.

P. Wang, C. Ballestrem, and C. H. Streuli, The C terminus of talin links integrins to cell cycle progression, The Journal of Cell Biology, vol.195, issue.3, pp.499-513, 2011.

Y. Wang, Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis, International journal of colorectal disease, vol.22, issue.10, pp.1179-84, 2007.

Y. Wang and J. S. Lazo, Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion, Oncogene, issue.7, pp.818-827, 2012.

Y. Wang and M. A. Mcniven, Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex, The Journal of Cell Biology, vol.196, issue.3, 2012.

A. Weber, Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated kinase in malignant melanomas of the uvea. Laboratory investigation; a journal of technical methods and pathology, vol.83, pp.1771-1777, 2003.

B. Wehrle-haller, Assembly and disassembly of cell matrix adhesions. Current opinion in cell biology, vol.24, pp.569-81, 2012.

R. A. Weineberg, The Biology of Cancer, 2014.

K. Wennerberg, Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin beta1A. Requirement for threonines 788-789 in receptor activation, Journal of cell science, vol.111, pp.1117-1126, 1998.

K. C. Williams and M. G. Coppolino, Phosphorylation of Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) and Its Vesicle-associated Membrane Protein 7 (VAMP7)-dependent Trafficking Facilitate Cell Invasion and Migration, Journal of Biological Chemistry, vol.286, issue.50, pp.43405-43416, 2011.

S. E. Winograd-katz, The integrin adhesome: from genes and proteins to human disease, Nature Reviews: Molecular Cell Biology, vol.15, issue.4, pp.273-288, 2014.

A. M. Winter-vann and P. J. Casey, Post-prenylation-processing enzymes as new targets in oncogenesis, Nature reviews. Cancer, vol.5, issue.5, pp.405-417, 2005.

H. Wolfenson, I. Lavelin, and B. Geiger, Dynamic regulation of the structure and functions of integrin adhesions, Developmental cell, vol.24, issue.5, pp.447-58, 2013.

C. Xing, Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis, Cancer research, vol.76, issue.1, pp.83-95, 2016.

J. Xu, VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C, PloS one, vol.6, issue.11, p.27165, 2011.

Y. Xu, Expression and Prognostic Value of PRL-3 in Human Intrahepatic Cholangiocarcinoma, Pathology & Oncology Research, vol.16, issue.2, pp.169-175, 2010.

Y. Xu, Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion, The Journal of experimental medicine, vol.207, issue.11, pp.2421-2458, 2010.

Y. Yamaguchi and V. J. Hearing, Melanocytes and their diseases. Cold Spring Harbor perspectives in medicine, vol.4, p.17046, 2014.

S. Yamashita, Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, vol.13, pp.236-245, 2007.

D. Yan, MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met, Investigative ophthalmology & visual science, vol.50, issue.4, pp.1559-65, 2009.

T. O. Yarovinsky, Expression of the protein tyrosine phosphatase, phosphatase of regenerating liver 1, in the outer segments of primate cone photoreceptors, Brain research. Molecular brain research, vol.77, issue.1, pp.95-103, 2000.

K. Yasumoto, Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer, Cancer research, vol.66, issue.4, pp.2181-2188, 2006.

S. Yavuzyigitoglu, Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases, Ophthalmology, vol.123, issue.5, pp.1118-1146, 2016.

K. Yoshida, Frequent pathway mutations of splicing machinery in myelodysplasia, Nature, vol.478, issue.7367, pp.64-73, 2011.

F. Yu, Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP, Cancer Cell, vol.25, issue.6, pp.822-830, 2014.

F. X. Yu, B. Zhao, and K. L. Guan, Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer, Cell, vol.163, issue.4, pp.811-828, 2015.

H. Yu, Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair, Proceedings of the National Academy of Sciences, vol.111, issue.1, pp.285-290, 2014.

L. Yu, Oxidative stress-induced expression and modulation of Phosphatase of Regenerating Liver-1 (PRL-1) in mammalian retina, Biochimica et biophysica acta, vol.1773, issue.9, pp.1473-82, 2007.

R. Zaidel-bar and B. Geiger, The switchable integrin adhesome, Journal of cell science, vol.123, pp.1385-1388, 2010.

Q. Zeng, Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome, Journal of Biological Chemistry, vol.275, issue.28, pp.21444-21452, 2000.

Q. Zeng, PRL-3 and PRL-1 promote cell migration, invasion, and metastasis, Cancer research, vol.63, issue.11, pp.2716-2738, 2003.

Q. Zeng, W. Hong, and Y. H. Tan, Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochemical and biophysical research communications, vol.244, pp.421-428, 1998.

L. F. Zerbini, Computational repositioning and preclinical validation of pentamidine for renal cell cancer, Mol Cancer Ther, vol.144, issue.5, pp.724-732, 2008.

D. Zhang, Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals, The Journal of biological chemistry, vol.279, issue.19, pp.19683-90, 2004.

P. Zhang, Expression and its relationship of PRL-3 and RhoC in non-small cell lung cancer, Zhongguo fei ai za zhi = Chinese journal of lung cancer, vol.13, issue.6, pp.598-601, 2010.

X. Zhang, Talin depletion reveals independence of initial cell spreading from integrin activation and traction, Nature cell biology, vol.10, issue.9, pp.1062-1070, 2008.

G. Zhao, Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value, 2008.

, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, vol.11, pp.487-91

P. Zheng, Snail as a key regulator of PRL-3 gene in colorectal cancer, Cancer Biology & Therapy, vol.12, issue.8, pp.742-749, 2011.

P. Zheng, Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer, Journal of Proteome Research, vol.9, issue.10, pp.4897-4905, 2010.

G. Zhou, Z. Q. Bao, and J. E. Dixon, Components of a new human protein kinase signal transduction pathway, The Journal of biological chemistry, vol.270, issue.21, pp.12665-12674, 1995.

H. Zhou, 1H, 13C and 15N resonance assignments and secondary structure of the human protein tyrosine phosphatase, PRL-2, Journal of biomolecular NMR, vol.27, issue.4, pp.397-405, 2003.

J. Zhou, Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma, International Journal of Cancer, vol.124, issue.8, pp.1879-1886, 2009.

J. Zhou, Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia, Experimental Hematology, vol.42, issue.12, pp.1041-1052, 2014.

L. E. Zimmerman and I. W. Mclean, The natural course of untreated uveal melanomas. Documenta ophthalmologica, Advances in ophthalmology, vol.50, issue.1, pp.75-82, 1980.

M. W. Zimmerman, Protein-tyrosine Phosphatase 4A3 (PTP4A3) Promotes Vascular Endothelial Growth Factor Signaling and Enables Endothelial Cell Motility, Journal of Biological Chemistry, vol.289, issue.9, pp.5904-5913, 2014.

M. W. Zimmerman, G. E. Homanics, and J. S. Lazo, Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer, PloS one, vol.8, issue.3, p.58300, 2013.

W. Zuidervaart, Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS, British Journal of Cancer, vol.92, issue.11, pp.2032-2040, 2005.